Literature DB >> 9650959

Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.

D A Sack1, A J Lastovica, S H Chang, G Pazzaglia.   

Abstract

Campylobacter jejuni with Gm1 ganglioside in the core of its lipopolysaccharide has been associated with Guillain-Barré syndrome. Since this epitope may be of considerable pathophysiologic importance and since this ganglioside binds cholera toxin, a rapid screening assay to detect bacteria that bind cholera toxin as an indication of Gm1 on their surfaces was developed. In the assay, bacterial lawns were grown on agar plates, harvested with phosphate-buffered saline, boiled, and incubated with a standard concentration of cholera B subunit. Preparations from strains with Gm1 were observed to inhibit the binding of cholera B subunit to Gm1 in a microtiter enzyme-linked immunosorbent assay. By using this assay with two groups of strains, 37 positive strains were detected among the 197 tested. Species with positive isolates included C. jejuni, Campylobacter coli, and Helicobacter pylori. The assay is capable of testing large numbers of isolates and should prove useful in future clinical and epidemiological studies of bacteria with this epitope.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650959      PMCID: PMC104975     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Experimental Campylobacter jejuni infection in humans.

Authors:  R E Black; M M Levine; M L Clements; T P Hughes; M J Blaser
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

2.  Differentiation of enteropathogenic Campylobacter.

Authors:  M B Skirrow; J Benjamin
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

Review 3.  Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.

Authors:  N Yuki
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

4.  Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.

Authors:  G O Aspinall; A G McDonald; H Pang
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

5.  Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin.

Authors:  D A Sack; S Huda; P K Neogi; R R Daniel; W M Spira
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

Review 6.  Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.

Authors:  B Mishu; M J Blaser
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

7.  Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens.

Authors:  J L Penner; J N Hennessy; R V Congi
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

8.  Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids.

Authors:  J Holmgren; I Lönnroth; L Svennerholm
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

9.  Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope.

Authors:  N Yuki; T Taki; M Takahashi; K Saito; T Tai; T Miyatake; S Handa
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.

Authors:  N Yuki; T Taki; F Inagaki; T Kasama; M Takahashi; K Saito; S Handa; T Miyatake
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  7 in total

1.  Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndrome.

Authors:  T M Wassenaar; B N Fry; A J Lastovica; J A Wagenaar; P J Coloe; B Duim
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

3.  Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.

Authors:  M M Prendergast; T U Kosunen; A P Moran
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.

Authors:  Irving Nachamkin; Jirong Liu; Ming Li; Huong Ung; Anthony P Moran; Martina M Prendergast; Kazim Sheikh
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

5.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 6.  Acute myelitis of children with positive anti-GM1 antibody: Case series and literature review.

Authors:  Zhiling Wang; Di Qie; Hui Zhou; Xiao Tang Cai
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

7.  Unique repertoire of anti-carbohydrate antibodies in individual human serum.

Authors:  Ralph N D Luetscher; Tanya R McKitrick; Chao Gao; Akul Y Mehta; Alyssa M McQuillan; Robert Kardish; Kayluz Frias Boligan; Xuezheng Song; Lenette Lu; Jamie Heimburg-Molinaro; Stephan von Gunten; Galit Alter; Richard D Cummings
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.